Nynomic AG

M7U

Equity

ISIN DE000A0MSN11 / Valor 3197806

Xetra (2024-09-13)

EUR 19.70%

Nynomic AG
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

Nynomic AG is a leading manufacturer of smart photonic solutions for permanent, non-contact, and non-destructive optical measurement technology. The company's products are based on a technology platform utilizing spectral sensor technology, allowing for scalability into various application areas and providing significant efficiency gains for customers. Nynomic AG focuses on economically robust markets such as life science, green tech, and clean tech, offering a full range of services from components to devices. With a global presence and a buy-and-build strategy in place, the company aims for above-average growth and increased profitability through synergy effects. Founded in 1995 as m-u-t GmbH and later converted into m-u-t AG before becoming Nynomic AG, the company has established itself as an internationally renowned high-tech corporation in the optical measurement technology sector.

Summarized from source with an LLMView SourceSector: Technology

Revenue Performance

Nynomic AG reported consolidated revenue of EUR 52.8 million for the first half of 2023, a slight decrease of 3% compared to EUR 54.2 million in the same period of the previous year. This performance was in line with expectations, considering the anticipated volatility throughout the year.

EBIT and EBIT Margin

The company's EBIT for the first half of 2023 was EUR 4.6 million, down 35% from EUR 7.0 million in the first half of 2022. The EBIT margin also decreased to 8.6% from 12.9% in the previous year, reflecting the challenging economic environment.

Balance Sheet Strength

As of June 30, 2023, Nynomic AG's equity increased by 26% to EUR 97.1 million from EUR 77.0 million at the end of 2022. Financial liabilities were reduced by 52% to EUR 8.1 million, and the equity ratio improved to 66.7% from 55.6%, indicating a stronger financial position.

Segment Sales

In the first half of 2023, Nynomic AG's Clean Tech segment generated EUR 36.2 million in sales, a 4% decrease from the previous year. The Life Science segment saw a 7% decline to EUR 7.7 million, while the Green Tech segment grew by 8% to EUR 8.9 million, showcasing mixed performance across different business areas.

Geographical Sales Distribution

Sales in Germany, Europe, and other remaining countries remained stable at EUR 30.3 million in the first half of 2023. Sales in America slightly decreased by 1% to EUR 16.3 million, while sales in Asia dropped by 17% to EUR 6.3 million, reflecting regional variations in market demand.

Summarized from source with an LLMView Source

Key figures

-37.3%1Y

-59.6%3Y

25.9%5Y

Performance

39.7%1Y

46.1%3Y

48.8%5Y

Volatility